Financials
Financial year 2024
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Revenue
€ 354,827
▲ 59% vs 2023
Profit
Caution€ -624,006
▼ 3% vs 2023
Debts
High€ 2.1 million
▲ 24% vs 2023
OXYPOINT from Niel, company number BE0832604943, closed financial year 2024 with a result of € -624,006 after tax. For that financial year OXYPOINT recorded revenue of € 354,827 and equity of € -747,099. Compared with financial year 2023, the result moved from € -604,831 to € -624,006. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2025.
What happened at OXYPOINT?
What happened at OXYPOINT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- P& L PROJECTS stepped down as director. NBB
- STARTEGICA stepped down as director. NBB
- New annual accounts for financial year 2024: loss of € 624,006. Source: NBB ↗
- GEO-PHARM stepped down as director. NBB
- GEO-PHARM became a director. NBB
- Innovamus stepped down as director. NBB
- COFIMA stepped down as director. NBB
- STARTEGICA became a director. NBB
In short
From € 515,912 loss in 2021 to € 624,006 loss in 2024.
Paid € 2,322 in corporate taxes since 2021.
A new publication or filing at OXYPOINT? We notify you, reason included.
Follow OXYPOINTNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2024 annual accounts
COFIMA
Director · represented by LUC HANSEN
since 2021 · until 2024
Director · represented by FRANK PIETERS
since 2022 · until 2027
Director · represented by Thiéry Damien
since 2024 · until 2025
Director · represented by Guy Lefever
since 2022 · until 2027
Director · represented by PHILIP HENDRICKX
since 2018 · until 2024
Establishments
Establishment units
Physical locations of this company
Galileilaan 15
2845 Niel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 21 companies are registered at this address.
KARDECO
€ -40,718 gross margin · 2025
ADM
€ 178,215 gross margin · 2023
CAST4ALL
€ -46,308 gross margin · 2025
UBIS
€ 237,171 gross margin · 2025
Hemplab Institute
€ -1,306 gross margin · 2025
+16 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Domain
Domain
oxypoint.eu
Registrar
Combell NV
Website info
Features
Security
Details
- Company number
- 0832.604.943
- VAT number
- BE 0832.604.943
- Registered office
- Galileilaan 15, 2845 Niel
- Names & denominations
- OXYPOINT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Opening faillissement
- Start date
- 6 January 2011
- Peppol
- Not registered
- Contact
- oxypoint.eu info@oxypoint.eu
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Verhuur en lease van medisch en paramedisch materieel
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied